NPPA is an attached office of the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers. It acts as an independent Regulator for pricing of drugs and to ensure availability and accessibility of medicines at affordable prices.
Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
EXAMIANS